• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

髓源性抑制细胞作为器官移植中免疫调节的一种作用。

Myeloid-Derived Suppressor Cells as a Regulator of Immunity in Organ Transplantation.

机构信息

Department of Organ Transplantation and General Surgery, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.

出版信息

Int J Mol Sci. 2018 Aug 10;19(8):2357. doi: 10.3390/ijms19082357.

DOI:10.3390/ijms19082357
PMID:30103447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6121658/
Abstract

Regulation of allo-immune responses is proposed as a topic for investigation in the current field of organ transplantation. As a regulator, regulatory T cells (Tregs) have received attention due to their ability to control allograft rejection. Concurrently, however, the independent action of Tregs is not enough to achieve tolerance status in many situations. Meanwhile, as a multi-functional regulator, myeloid-derived suppressor cells (MDSCs) can suppress effector T cells as well as induce Tregs or regulatory B cells (Bregs) in certain circumstances. Furthermore, the importance of a crosstalk between MDSCs and natural killer T cells to induce tolerance has been reported. Thus, orchestration between MDSCs, myeloid regulators, T/Bregs and other lymphoid/myeloid regulators can shed light on achieving allogeneic tolerance. Here, we review the current knowledge in terms of immunological regulatory function displayed by MDSCs in the context of organ transplantation. Ideal control of MDSCs would lead to a reduction of allograft rejection and subsequent long-term allograft acceptance.

摘要

调节同种免疫反应被提议作为当前器官移植领域的研究课题。作为一种调节剂,调节性 T 细胞(Tregs)因其能够控制同种异体移植物排斥而受到关注。然而,在许多情况下,Tregs 的独立作用不足以达到耐受状态。同时,作为一种多功能调节剂,髓源性抑制细胞(MDSCs)在某些情况下可以抑制效应 T 细胞,并诱导 Tregs 或调节性 B 细胞(Bregs)。此外,已经报道了 MDSCs 与自然杀伤 T 细胞之间的串扰在诱导耐受中的重要性。因此,MDSCs、髓系调节物、T/Bregs 和其他淋巴/髓系调节物之间的协调可以阐明实现同种异体耐受的机制。在这里,我们综述了 MDSCs 在器官移植背景下所表现出的免疫调节功能的最新知识。理想地控制 MDSCs 将导致移植物排斥反应的减少和随后的长期移植物接受。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13b6/6121658/df4d05bccdd4/ijms-19-02357-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13b6/6121658/d54d625bb38c/ijms-19-02357-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13b6/6121658/df4d05bccdd4/ijms-19-02357-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13b6/6121658/d54d625bb38c/ijms-19-02357-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13b6/6121658/df4d05bccdd4/ijms-19-02357-g002.jpg

相似文献

1
Myeloid-Derived Suppressor Cells as a Regulator of Immunity in Organ Transplantation.髓源性抑制细胞作为器官移植中免疫调节的一种作用。
Int J Mol Sci. 2018 Aug 10;19(8):2357. doi: 10.3390/ijms19082357.
2
Myeloid-derived Suppressor Cells Recruit CD4(+)/Foxp3(+) Regulatory T Cells in a Murine Cardiac Allograft.髓源性抑制细胞在小鼠心脏同种异体移植中招募CD4(+)/Foxp3(+)调节性T细胞。
Transplant Proc. 2016 May;48(4):1275-8. doi: 10.1016/j.transproceed.2015.10.060.
3
The Crosstalk between Myeloid Derived Suppressor Cells and Immune Cells: To Establish Immune Tolerance in Transplantation.髓系来源抑制细胞与免疫细胞的串扰:在移植中建立免疫耐受。
J Immunol Res. 2016;2016:4986797. doi: 10.1155/2016/4986797. Epub 2016 Oct 27.
4
Dexamethasone-Induced Myeloid-Derived Suppressor Cells Prolong Allo Cardiac Graft Survival through iNOS- and Glucocorticoid Receptor-Dependent Mechanism.地塞米松诱导的髓源性抑制细胞通过 iNOS 和糖皮质激素受体依赖的机制延长同种异体心脏移植物的存活。
Front Immunol. 2018 Feb 15;9:282. doi: 10.3389/fimmu.2018.00282. eCollection 2018.
5
The Effect of Immunosuppressive Drugs on MDSCs in Transplantation.免疫抑制剂对移植中 MDSCs 的影响。
J Immunol Res. 2018 Jul 3;2018:5414808. doi: 10.1155/2018/5414808. eCollection 2018.
6
Myeloid-derived suppressor cells depletion may cause pregnancy loss via upregulating the cytotoxicity of decidual natural killer cells.髓系来源的抑制细胞耗竭可能通过上调蜕膜自然杀伤细胞的细胞毒性导致妊娠丢失。
Am J Reprod Immunol. 2019 Apr;81(4):e13099. doi: 10.1111/aji.13099. Epub 2019 Mar 4.
7
Myeloid-derived suppressor cells in transplantation tolerance induction.移植耐受诱导中的髓源抑制性细胞。
Int Immunopharmacol. 2020 Jun;83:106421. doi: 10.1016/j.intimp.2020.106421. Epub 2020 Mar 24.
8
Analysis of therapeutic potential of monocytic myeloid-derived suppressor cells in cardiac allotransplantation.分析单核细胞来源的髓样抑制细胞在心脏同种异体移植中的治疗潜力。
Transpl Immunol. 2021 Aug;67:101405. doi: 10.1016/j.trim.2021.101405. Epub 2021 May 8.
9
In vivo induction of myeloid suppressor cells and CD4(+)Foxp3(+) T regulatory cells prolongs skin allograft survival in mice.在体内诱导髓系抑制细胞和 CD4(+)Foxp3(+)T 调节细胞可延长小鼠皮肤移植物的存活时间。
Cell Transplant. 2011;20(6):941-54. doi: 10.3727/096368910X540621. Epub 2010 Nov 5.
10
PMA induces the differentiation of monocytes into immunosuppressive MDSCs.PMA 诱导单核细胞分化为免疫抑制性 MDSCs。
Clin Exp Immunol. 2021 Nov;206(2):216-225. doi: 10.1111/cei.13657. Epub 2021 Sep 9.

引用本文的文献

1
Regulatory Immune Cell-derived Exosomes: Modes of Action and Therapeutic Potential in Transplantation.调节性免疫细胞衍生的外泌体:移植中的作用模式及治疗潜力
Transplantation. 2025 Jul 1;109(7):1124-1137. doi: 10.1097/TP.0000000000005309. Epub 2025 Jan 27.
2
New Scenarios in Liver Transplantation for Hepatocellular Carcinoma.肝细胞癌肝移植的新情况
Liver Int. 2025 Apr;45(4):e16142. doi: 10.1111/liv.16142. Epub 2024 Nov 4.
3
The need for paradigm shift: prognostic significance and implications of standard therapy-related systemic immunosuppression in glioblastoma for immunotherapy and oncolytic virotherapy.

本文引用的文献

1
TIGIT iTregs elicited by human regulatory macrophages control T cell immunity.调节性巨噬细胞诱导的 TIGIT+iTregs 抑制 T 细胞免疫。
Nat Commun. 2018 Jul 20;9(1):2858. doi: 10.1038/s41467-018-05167-8.
2
Immunomodulatory Function of Myeloid-Derived Suppressor Cells during B Cell-Mediated Immune Responses.髓系来源抑制细胞在 B 细胞介导的免疫应答中的免疫调节功能。
Int J Mol Sci. 2018 May 15;19(5):1468. doi: 10.3390/ijms19051468.
3
Indoleamine 2,3-dioxygenase 1 inhibition targets anti-PD1-resistant lung tumors by blocking myeloid-derived suppressor cells.
范式转变的必要性:标准治疗相关全身免疫抑制在胶质母细胞瘤中对免疫治疗和溶瘤病毒治疗的预后意义和影响。
Front Immunol. 2024 Feb 8;15:1326757. doi: 10.3389/fimmu.2024.1326757. eCollection 2024.
4
Local Myeloid-Derived Suppressor Cells Impair Progression of Experimental Autoimmune Uveitis by Alleviating Oxidative Stress and Inflammation.局部髓系来源的抑制细胞通过减轻氧化应激和炎症来抑制实验性自身免疫性葡萄膜炎的进展。
Invest Ophthalmol Vis Sci. 2023 Oct 3;64(13):39. doi: 10.1167/iovs.64.13.39.
5
Genomic landscape and expression profile of consensus molecular subtype four of colorectal cancer.结直肠癌共识分子亚型四的基因组景观和表达谱。
Front Immunol. 2023 Jun 19;14:1160052. doi: 10.3389/fimmu.2023.1160052. eCollection 2023.
6
Adjuvant conditioning induces an immunosuppressive milieu that delays alloislet rejection through the expansion of myeloid-derived suppressor cells.辅助调节诱导产生免疫抑制微环境,通过髓系来源的抑制细胞的扩增来延迟同种异体胰岛排斥。
Am J Transplant. 2023 Jul;23(7):935-945. doi: 10.1016/j.ajt.2023.04.015. Epub 2023 Apr 18.
7
A Lesson of Immunosuppression in Renal Transplant: Retreat or Hold?肾移植中的免疫抑制教训:撤退还是坚守?
Yale J Biol Med. 2023 Mar 31;96(1):57-77. doi: 10.59249/XGIO3365. eCollection 2023 Mar.
8
The Current and Future Promises of Combination Radiation and Immunotherapy for Genitourinary Cancers.放射治疗与免疫治疗联合用于泌尿生殖系统癌症的现状与未来前景
Cancers (Basel). 2022 Dec 25;15(1):127. doi: 10.3390/cancers15010127.
9
Exosomes Derived from RM-1 Cells Promote the Recruitment of MDSCs into Tumor Microenvironment by Upregulating CXCR4 via TLR2/NF-B Pathway.源自RM-1细胞的外泌体通过TLR2/NF-κB通路上调CXCR4促进髓源性抑制细胞募集至肿瘤微环境
J Oncol. 2021 Oct 8;2021:5584406. doi: 10.1155/2021/5584406. eCollection 2021.
10
Increase in polymorphonuclear myeloid-derived suppressor cells and regulatory T-cells in children with B-cell acute lymphoblastic leukemia.B 细胞急性淋巴细胞白血病患儿中性粒细胞髓系来源的抑制细胞和调节性 T 细胞增多。
Sci Rep. 2021 Jul 22;11(1):15039. doi: 10.1038/s41598-021-94469-x.
吲哚胺 2,3-双加氧酶 1 抑制通过阻断髓系来源的抑制细胞靶向抗 PD-1 耐药的肺肿瘤。
Cancer Lett. 2018 Sep 1;431:54-63. doi: 10.1016/j.canlet.2018.05.005. Epub 2018 May 8.
4
Blockade of Myeloid-Derived Suppressor Cell Expansion with All- Retinoic Acid Increases the Efficacy of Antiangiogenic Therapy.全反式维甲酸阻断髓源性抑制细胞扩增可增强抗血管生成治疗的疗效。
Cancer Res. 2018 Jun 15;78(12):3220-3232. doi: 10.1158/0008-5472.CAN-17-3415. Epub 2018 Apr 19.
5
Glyteer, Soybean Tar, Impairs IL-4/Stat6 Signaling in Murine Bone Marrow-Derived Dendritic Cells: The Basis of Its Therapeutic Effect on Atopic Dermatitis.Glyteer(甘油松香酯)、大豆焦油,损害了小鼠骨髓来源树突状细胞中的 IL-4/Stat6 信号通路:其治疗特应性皮炎的作用基础。
Int J Mol Sci. 2018 Apr 12;19(4):1169. doi: 10.3390/ijms19041169.
6
Induced pluripotent stem cells-derived myeloid-derived suppressor cells regulate the CD8 T cell response.诱导多能干细胞衍生的髓源性抑制细胞调节CD8 T细胞反应。
Stem Cell Res. 2018 May;29:32-41. doi: 10.1016/j.scr.2018.03.009. Epub 2018 Mar 16.
7
Regulation and Function of the PD-L1 Checkpoint.PD-L1 检查点的调控与功能
Immunity. 2018 Mar 20;48(3):434-452. doi: 10.1016/j.immuni.2018.03.014.
8
Characterization of Multiple Cytokine Combinations and TGF-β on Differentiation and Functions of Myeloid-Derived Suppressor Cells.多种细胞因子组合和 TGF-β 对髓源性抑制细胞分化和功能的影响。
Int J Mol Sci. 2018 Mar 15;19(3):869. doi: 10.3390/ijms19030869.
9
Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form.靶向免疫调节酶吲哚胺 2,3-双加氧酶的去辅基形式可有效抑制其活性。
Proc Natl Acad Sci U S A. 2018 Mar 27;115(13):3249-3254. doi: 10.1073/pnas.1719190115. Epub 2018 Mar 12.
10
Myeloid-derived suppressor cells increase and inhibit donor-reactive T cell responses to graft intestinal epithelium in intestinal transplant patients.髓源性抑制细胞增加并抑制移植物肠道上皮的供体反应性 T 细胞反应在肠移植患者中。
Am J Transplant. 2018 Oct;18(10):2544-2558. doi: 10.1111/ajt.14718. Epub 2018 Apr 17.